Quarterly Holdings Report
for
Fidelity® Small Cap Growth Fund
April 30, 2025
SCP-NPRT3-0625
1.815773.120
Common Stocks - 98.8%
 
 
Shares
Value ($)
 
BAHAMAS (NASSAU) - 0.2%
 
 
 
Consumer Discretionary - 0.2%
 
 
 
Diversified Consumer Services - 0.2%
 
 
 
OneSpaWorld Holdings Ltd
 
920,817
15,377,644
BELGIUM - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Health Care Equipment & Supplies - 0.0%
 
 
 
Nyxoah SA (United States) (b)(c)
 
452,657
2,779,314
CANADA - 2.0%
 
 
 
Consumer Discretionary - 0.2%
 
 
 
Specialty Retail - 0.2%
 
 
 
Aritzia Inc Subordinate Voting Shares (c)
 
450,147
15,833,184
Energy - 0.1%
 
 
 
Energy Equipment & Services - 0.1%
 
 
 
CES Energy Solutions Corp
 
1,879,260
8,288,046
Health Care - 0.4%
 
 
 
Biotechnology - 0.3%
 
 
 
Xenon Pharmaceuticals Inc (c)
 
480,344
18,349,141
Health Care Providers & Services - 0.1%
 
 
 
dentalcorp Holdings Ltd Subordinate Voting Shares
 
1,741,800
10,625,662
TOTAL HEALTH CARE
 
 
28,974,803
 
 
 
 
Information Technology - 0.8%
 
 
 
Electronic Equipment, Instruments & Components - 0.2%
 
 
 
Kraken Robotics Inc (c)
 
5,298,900
9,455,458
Software - 0.6%
 
 
 
Lumine Group Inc Subordinate Voting Shares (c)(d)
 
414,900
13,413,675
TECSYS Inc
 
702,728
21,602,795
 
 
 
35,016,470
TOTAL INFORMATION TECHNOLOGY
 
 
44,471,928
 
 
 
 
Materials - 0.5%
 
 
 
Metals & Mining - 0.5%
 
 
 
G Mining Ventures Corp
 
700,400
9,713,947
Orla Mining Ltd (c)
 
956,300
10,529,983
Torex Gold Resources Inc (c)
 
339,880
11,008,010
 
 
 
31,251,940
TOTAL CANADA
 
 
128,819,901
DENMARK - 0.5%
 
 
 
Health Care - 0.5%
 
 
 
Biotechnology - 0.5%
 
 
 
Ascendis Pharma A/S ADR (c)
 
198,344
33,805,751
INDIA - 0.6%
 
 
 
Industrials - 0.6%
 
 
 
Professional Services - 0.6%
 
 
 
WNS Holdings Ltd ADR (c)
 
641,540
38,826,001
ISRAEL - 1.3%
 
 
 
Information Technology - 1.3%
 
 
 
IT Services - 0.3%
 
 
 
Wix.com Ltd (c)
 
134,958
22,887,527
Semiconductors & Semiconductor Equipment - 0.3%
 
 
 
Nova Ltd (c)
 
108,379
21,265,044
Software - 0.7%
 
 
 
Cellebrite DI Ltd (c)
 
2,163,667
42,818,970
TOTAL ISRAEL
 
 
86,971,541
ITALY - 0.4%
 
 
 
Industrials - 0.4%
 
 
 
Electrical Equipment - 0.4%
 
 
 
Prysmian SpA
 
449,231
24,677,250
JAPAN - 0.9%
 
 
 
Industrials - 0.5%
 
 
 
Professional Services - 0.5%
 
 
 
BayCurrent Inc
 
630,768
33,988,055
Information Technology - 0.4%
 
 
 
Semiconductors & Semiconductor Equipment - 0.4%
 
 
 
Allegro MicroSystems Inc (c)
 
1,273,726
24,289,954
TOTAL JAPAN
 
 
58,278,009
NETHERLANDS - 0.6%
 
 
 
Health Care - 0.6%
 
 
 
Biotechnology - 0.4%
 
 
 
Merus NV (b)(c)
 
550,824
25,068,000
Pharmaceuticals - 0.2%
 
 
 
Pharvaris NV (c)
 
728,094
13,455,177
TOTAL NETHERLANDS
 
 
38,523,177
SWEDEN - 0.2%
 
 
 
Industrials - 0.2%
 
 
 
Trading Companies & Distributors - 0.2%
 
 
 
Alligo AB B Shares
 
889,104
10,137,009
THAILAND - 0.9%
 
 
 
Information Technology - 0.9%
 
 
 
Electronic Equipment, Instruments & Components - 0.9%
 
 
 
Fabrinet (c)
 
272,861
55,952,877
UNITED KINGDOM - 1.0%
 
 
 
Consumer Discretionary - 0.5%
 
 
 
Leisure Products - 0.5%
 
 
 
Games Workshop Group PLC
 
165,159
33,918,551
Energy - 0.4%
 
 
 
Energy Equipment & Services - 0.4%
 
 
 
TechnipFMC PLC
 
865,214
24,373,078
Financials - 0.1%
 
 
 
Banks - 0.1%
 
 
 
Starling Bank Ltd Class D (c)(e)(f)
 
1,942,800
6,265,790
TOTAL UNITED KINGDOM
 
 
64,557,419
UNITED STATES - 90.2%
 
 
 
Communication Services - 1.2%
 
 
 
Entertainment - 0.4%
 
 
 
IMAX Corp (b)(c)
 
1,123,714
27,339,962
Interactive Media & Services - 0.3%
 
 
 
Cars.com Inc (c)
 
1,588,919
18,495,017
Media - 0.2%
 
 
 
Magnite Inc (b)(c)
 
985,170
11,713,671
TechTarget Inc/old (b)
 
18,712
149,134
 
 
 
11,862,805
Wireless Telecommunication Services - 0.3%
 
 
 
Gogo Inc (b)(c)
 
2,884,373
21,834,704
TOTAL COMMUNICATION SERVICES
 
 
79,532,488
 
 
 
 
Consumer Discretionary - 10.0%
 
 
 
Automobile Components - 0.0%
 
 
 
Modine Manufacturing Co (c)
 
22,390
1,827,920
Diversified Consumer Services - 2.3%
 
 
 
Adtalem Global Education Inc (c)
 
394,560
41,902,272
Duolingo Inc Class A (c)
 
110,881
43,185,932
Grand Canyon Education Inc (c)
 
211,145
37,661,934
Stride Inc (c)
 
46,425
6,603,955
Universal Technical Institute Inc (c)
 
856,775
24,041,107
 
 
 
153,395,200
Hotels, Restaurants & Leisure - 3.1%
 
 
 
Brinker International Inc (c)
 
340,122
45,678,385
Cava Group Inc (c)
 
223,408
20,649,601
Cheesecake Factory Inc/The (b)
 
525,400
26,464,398
Dutch Bros Inc Class A (c)
 
367,763
21,970,162
Kura Sushi USA Inc Class A (b)(c)
 
221,273
13,028,553
Planet Fitness Inc Class A (c)
 
274,570
25,971,576
Red Rock Resorts Inc Class A
 
375,615
16,038,761
Sportradar Holding AG Class A (b)(c)
 
1,338,960
30,943,366
 
 
 
200,744,802
Household Durables - 1.1%
 
 
 
Champion Homes Inc (c)
 
430,670
37,252,955
Newell Brands Inc
 
2,118,933
10,128,499
Somnigroup International Inc
 
379,510
23,172,881
 
 
 
70,554,335
Specialty Retail - 3.2%
 
 
 
Boot Barn Holdings Inc (c)
 
311,935
32,547,298
Chewy Inc Class A (c)
 
1,376,577
51,621,638
Fanatics Inc Class A (c)(e)(f)
 
726,062
44,217,176
Group 1 Automotive Inc
 
86,366
34,859,909
Murphy USA Inc
 
38,956
19,422,292
Warby Parker Inc Class A (c)
 
1,573,140
25,972,541
 
 
 
208,640,854
Textiles, Apparel & Luxury Goods - 0.3%
 
 
 
Crocs Inc (c)
 
230,840
22,257,593
TOTAL CONSUMER DISCRETIONARY
 
 
657,420,704
 
 
 
 
Consumer Staples - 3.4%
 
 
 
Beverages - 0.6%
 
 
 
Primo Brands Corp Class A
 
1,265,640
41,348,459
Consumer Staples Distribution & Retail - 1.8%
 
 
 
Sprouts Farmers Market Inc (c)
 
384,371
65,727,441
US Foods Holding Corp (c)
 
730,842
47,987,086
 
 
 
113,714,527
Food Products - 0.7%
 
 
 
Freshpet Inc (c)
 
108,500
7,979,090
Simply Good Foods Co/The (c)
 
1,117,000
40,334,870
 
 
 
48,313,960
Tobacco - 0.3%
 
 
 
Turning Point Brands Inc
 
356,840
21,902,839
TOTAL CONSUMER STAPLES
 
 
225,279,785
 
 
 
 
Energy - 1.2%
 
 
 
Energy Equipment & Services - 0.4%
 
 
 
Cactus Inc Class A
 
640,636
24,305,730
Oil, Gas & Consumable Fuels - 0.8%
 
 
 
Antero Resources Corp (c)
 
870,693
30,326,237
Centrus Energy Corp Class A (b)(c)
 
133,166
9,227,072
Northern Oil & Gas Inc
 
582,120
14,145,516
 
 
 
53,698,825
TOTAL ENERGY
 
 
78,004,555
 
 
 
 
Financials - 8.1%
 
 
 
Banks - 1.2%
 
 
 
Eastern Bankshares Inc
 
1,760,318
26,263,945
Pathward Financial Inc
 
88,374
7,014,244
Pinnacle Financial Partners Inc
 
256,613
25,722,887
SouthState Corp
 
227,920
19,778,898
 
 
 
78,779,974
Capital Markets - 3.8%
 
 
 
Houlihan Lokey Inc Class A
 
236,220
38,286,538
P10 Inc Class A
 
2,025,460
22,421,842
Perella Weinberg Partners (f)
 
2,039,500
35,018,215
Perella Weinberg Partners Class A
 
496,680
8,527,996
Piper Sandler Cos
 
85,150
20,531,368
PJT Partners Inc Class A (b)
 
156,570
22,187,535
StepStone Group Inc Class A
 
885,347
44,276,203
StepStone Group Inc rights 12/31/2038 (c)(e)
 
31,066
1,959,022
Stifel Financial Corp
 
629,619
53,952,052
 
 
 
247,160,771
Consumer Finance - 1.0%
 
 
 
FirstCash Holdings Inc
 
327,244
43,837,606
SLM Corp
 
804,600
23,260,986
 
 
 
67,098,592
Financial Services - 1.0%
 
 
 
HA Sustainable Infrastructure Capital Inc
 
812,922
20,306,792
Mr Cooper Group Inc (c)
 
126,820
15,092,847
Remitly Global Inc (c)
 
1,477,570
29,876,465
 
 
 
65,276,104
Insurance - 1.1%
 
 
 
Baldwin Insurance Group Inc/The Class A (c)
 
713,862
29,710,937
Stewart Information Services Corp
 
361,459
23,668,335
Trupanion Inc (b)(c)
 
568,880
20,821,008
 
 
 
74,200,280
TOTAL FINANCIALS
 
 
532,515,721
 
 
 
 
Health Care - 27.1%
 
 
 
Biotechnology - 12.0%
 
 
 
ADMA Biologics Inc (c)
 
977,761
23,270,712
Aerovate Therapeutics Inc (f)
 
348,441
3,310,190
Alkermes PLC (c)
 
896,170
25,782,811
Annexon Inc (b)(c)
 
1,331,756
2,477,066
Apogee Therapeutics Inc (b)(c)
 
280,400
11,005,700
Arcellx Inc (c)
 
546,065
35,466,922
Astria Therapeutics Inc (c)
 
1,354,456
6,988,993
Avidity Biosciences Inc (b)(c)
 
498,742
16,283,926
Bicara Therapeutics Inc (b)
 
464,000
6,667,680
Blueprint Medicines Corp (b)(c)
 
224,318
20,076,461
Boundless Bio Inc (b)(c)
 
295,867
520,726
Cargo Therapeutics Inc (c)
 
930,625
4,252,956
Celldex Therapeutics Inc (c)
 
475,254
9,899,541
CG oncology Inc (b)(c)
 
832,900
22,438,326
Cogent Biosciences Inc (c)
 
2,573,120
13,405,955
Crinetics Pharmaceuticals Inc (c)
 
891,815
29,777,703
Cytokinetics Inc (c)
 
538,529
23,070,582
Day One Biopharmaceuticals Inc (b)(c)
 
1,587,480
12,350,594
Denali Therapeutics Inc (c)
 
614,814
10,236,653
Disc Medicine Inc (c)
 
279,000
13,788,180
GlycoMimetics Inc (e)(f)(g)(h)
 
12,099,897
2,725,986
Insmed Inc (b)(c)
 
651,280
46,892,160
Janux Therapeutics Inc (c)
 
696,570
23,126,124
Kiniksa Pharmaceuticals International Plc Class A (c)
 
490,295
13,223,256
Korro Bio Inc (b)(c)
 
51,600
915,900
Legend Biotech Corp ADR (c)
 
311,867
10,899,752
Madrigal Pharmaceuticals Inc (b)(c)
 
170,076
56,790,078
Monte Rosa Therapeutics Inc (b)(c)
 
620,976
3,048,992
MoonLake Immunotherapeutics Class A (c)
 
144,354
6,074,416
Neurogene Inc (b)(c)
 
288,922
4,333,830
Nurix Therapeutics Inc (c)
 
951,100
10,966,183
Nuvalent Inc Class A (c)
 
512,712
39,350,646
Oruka Therapeutics Inc
 
555,043
5,794,649
Perspective Therapeutics Inc (c)
 
1,164,200
2,852,290
PTC Therapeutics Inc (c)
 
422,200
21,042,448
Revolution Medicines Inc (c)
 
518,007
20,917,123
Rhythm Pharmaceuticals Inc (c)
 
577,390
37,640,054
Scholar Rock Holding Corp (c)
 
47,900
1,576,389
Soleno Therapeutics Inc (c)(g)
 
432,910
32,407,643
Spyre Therapeutics Inc (c)
 
501,773
7,642,003
TG Therapeutics Inc (c)
 
231,000
10,512,810
Tyra Biosciences Inc (b)(c)
 
913,433
9,408,360
Upstream Bio Inc (b)
 
1,226,600
11,358,316
Vaxcyte Inc (c)
 
746,435
26,752,230
Veracyte Inc (c)
 
741,120
22,604,160
Vericel Corp (c)
 
825,687
31,392,620
Viking Therapeutics Inc (b)(c)
 
323,282
9,333,151
Vir Biotechnology Inc (c)
 
292,100
1,787,652
Viridian Therapeutics Inc (c)
 
1,054,475
14,288,136
Zenas Biopharma Inc (b)
 
480,500
5,564,190
 
 
 
782,293,224
Health Care Equipment & Supplies - 6.5%
 
 
 
Artivion Inc (c)
 
616,484
14,604,506
AtriCure Inc (c)
 
523,733
15,664,854
Bioventus Inc (c)
 
35,965
262,903
Ceribell Inc (b)
 
1,339,826
21,557,800
Glaukos Corp (c)
 
429,894
40,517,510
Insulet Corp (c)
 
103,440
26,096,878
Integer Holdings Corp (c)
 
203,370
25,687,665
Lantheus Holdings Inc (c)
 
535,364
55,859,880
Masimo Corp (c)
 
261,995
42,170,715
Merit Medical Systems Inc (c)
 
385,600
36,419,920
NeuroPace Inc (c)
 
180,773
2,113,236
Penumbra Inc (c)
 
157,856
46,226,551
PROCEPT BioRobotics Corp (b)(c)
 
488,880
26,389,742
Pulmonx Corp (c)
 
1,493,472
7,213,470
TransMedics Group Inc (b)(c)
 
633,663
58,303,333
 
 
 
419,088,963
Health Care Providers & Services - 5.3%
 
 
 
agilon health Inc (c)
 
2,547,523
10,852,447
Alignment Healthcare Inc (c)
 
1,500,690
26,592,227
BrightSpring Health Services Inc (c)
 
2,714,456
47,584,414
Ensign Group Inc/The
 
467,345
60,282,832
GeneDx Holdings Corp Class A (c)
 
135,200
9,038,119
HealthEquity Inc (c)
 
677,617
58,085,329
LifeStance Health Group Inc (c)
 
3,324,142
21,839,613
Pennant Group Inc/The (c)
 
1,005,192
25,753,019
Privia Health Group Inc (c)
 
1,513,893
35,546,208
Progyny Inc (c)
 
1,570,390
35,867,708
Surgery Partners Inc (c)
 
790,643
17,354,614
 
 
 
348,796,530
Health Care Technology - 1.1%
 
 
 
Doximity Inc Class A (c)
 
935,150
53,191,332
Schrodinger Inc/United States (b)(c)
 
116,393
2,983,153
Waystar Holding Corp (c)
 
457,720
17,013,452
 
 
 
73,187,937
Life Sciences Tools & Services - 0.2%
 
 
 
Veterinary Emergency Group (c)(e)(f)(i)
 
190,561
13,834,729
Pharmaceuticals - 2.0%
 
 
 
Axsome Therapeutics Inc (c)
 
459,860
51,637,680
Corcept Therapeutics Inc (b)(c)
 
493,103
35,444,244
Enliven Therapeutics Inc (b)(c)
 
715,135
13,544,657
Enliven Therapeutics Inc (c)(f)
 
266,907
5,055,218
Liquidia Corp (b)(c)
 
605,500
8,458,835
Structure Therapeutics Inc ADR (c)
 
311,780
8,418,060
WaVe Life Sciences Ltd (c)
 
942,800
7,278,416
 
 
 
129,837,110
TOTAL HEALTH CARE
 
 
1,767,038,493
 
 
 
 
Industrials - 18.8%
 
 
 
Aerospace & Defense - 1.9%
 
 
 
BWX Technologies Inc
 
128,831
14,058,039
Leonardo DRS Inc
 
536,420
19,826,083
Mercury Systems Inc (c)
 
434,130
21,706,500
Rocket Lab USA Inc Class A (b)(c)
 
665,950
14,511,051
V2X Inc (c)
 
560,408
27,885,902
Woodward Inc
 
133,000
24,946,810
 
 
 
122,934,385
Building Products - 1.9%
 
 
 
AZZ Inc
 
778,276
67,523,226
CSW Industrials Inc (b)
 
34,897
10,904,615
Tecnoglass Inc
 
572,456
40,798,939
UFP Industries Inc
 
80,618
7,969,089
 
 
 
127,195,869
Commercial Services & Supplies - 1.7%
 
 
 
ACV Auctions Inc Class A (c)
 
2,126,374
31,236,434
GEO Group Inc/The (c)
 
1,790,664
56,011,970
HNI Corp
 
332,157
14,050,241
Montrose Environmental Group Inc (b)(c)
 
44,980
658,057
Pursuit Attractions and Hospitality Inc (c)
 
434,593
12,729,229
 
 
 
114,685,931
Construction & Engineering - 2.6%
 
 
 
Comfort Systems USA Inc
 
52,459
20,855,075
Construction Partners Inc Class A (c)
 
305,660
25,106,912
Fluor Corp (c)
 
1,246,436
43,488,152
Sterling Infrastructure Inc (c)
 
359,171
53,670,923
Valmont Industries Inc
 
83,498
24,483,284
 
 
 
167,604,346
Electrical Equipment - 0.3%
 
 
 
Acuity Inc
 
79,303
19,319,004
Machinery - 4.2%
 
 
 
Chart Industries Inc (c)
 
271,980
36,711,860
Crane Co
 
138,037
22,221,196
Esab Corp
 
299,226
35,943,027
Federal Signal Corp
 
205,364
16,722,791
Gates Industrial Corp PLC (c)
 
1,284,266
24,298,313
ITT Inc
 
260,956
35,756,191
JBT Marel Corp
 
144,480
15,207,965
Mueller Industries Inc
 
817,603
60,142,877
REV Group Inc
 
821,267
26,855,431
 
 
 
273,859,651
Passenger Airlines - 0.2%
 
 
 
Alaska Air Group Inc (c)
 
321,860
14,248,742
Professional Services - 3.9%
 
 
 
CACI International Inc (c)
 
54,490
24,949,336
Cbiz Inc (c)
 
432,446
29,449,573
ExlService Holdings Inc (c)
 
1,627,411
78,896,885
First Advantage Corp (b)(c)
 
1,041,684
14,687,744
FTI Consulting Inc (c)
 
52,060
8,656,537
Huron Consulting Group Inc (c)
 
258,890
34,895,783
KBR Inc
 
378,680
19,998,091
Paycom Software Inc
 
134,710
30,496,997
Paylocity Holding Corp (c)
 
79,820
15,333,422
 
 
 
257,364,368
Trading Companies & Distributors - 2.1%
 
 
 
Applied Industrial Technologies Inc
 
147,556
35,897,424
FTAI Aviation Ltd
 
451,613
48,372,269
Herc Holdings Inc (b)
 
221,053
24,192,040
Xometry Inc Class A (b)(c)
 
1,020,766
26,172,440
 
 
 
134,634,173
TOTAL INDUSTRIALS
 
 
1,231,846,469
 
 
 
 
Information Technology - 14.3%
 
 
 
Communications Equipment - 0.3%
 
 
 
Lumentum Holdings Inc (c)
 
306,660
18,105,205
Electronic Equipment, Instruments & Components - 3.9%
 
 
 
Advanced Energy Industries Inc
 
270,624
26,361,484
Badger Meter Inc
 
98,550
21,761,811
Belden Inc
 
189,583
19,547,903
OSI Systems Inc (b)(c)
 
521,080
106,685,920
PAR Technology Corp (b)(c)
 
453,051
26,458,178
TD SYNNEX Corp
 
321,252
35,594,722
Vontier Corp
 
565,708
17,995,171
 
 
 
254,405,189
IT Services - 0.7%
 
 
 
Kyndryl Holdings Inc (c)
 
1,472,021
47,722,921
Semiconductors & Semiconductor Equipment - 1.6%
 
 
 
Aehr Test Systems (b)(c)
 
900,069
7,677,589
Credo Technology Group Holding Ltd (c)
 
534,160
22,995,588
Impinj Inc (c)
 
131,000
12,069,030
MACOM Technology Solutions Holdings Inc (c)
 
392,644
40,736,815
SiTime Corp (c)
 
152,470
22,391,744
 
 
 
105,870,766
Software - 7.8%
 
 
 
Algolia Inc (c)(e)(f)
 
234,640
3,660,384
Alkami Technology Inc (c)
 
846,265
22,586,813
Clearwater Analytics Holdings Inc Class A (c)
 
376,960
8,572,070
Commvault Systems Inc (c)
 
278,070
46,473,839
Confluent Inc Class A (c)
 
220,600
5,252,486
CyberArk Software Ltd (c)
 
108,815
38,320,290
Five9 Inc (c)
 
29,880
751,183
Freshworks Inc Class A (c)
 
544,500
8,042,265
Intapp Inc (c)
 
692,188
37,558,121
InterDigital Inc (b)
 
79,430
15,965,430
Life360 Inc (b)(c)
 
487,286
20,904,569
Monday.com Ltd (c)
 
206,541
58,035,956
nCino Inc (b)(c)
 
1,535,377
35,620,746
Pegasystems Inc
 
139,940
12,885,675
Q2 Holdings Inc (c)
 
411,858
32,639,747
SailPoint Inc
 
740,760
12,711,442
SEMrush Holdings Inc Class A (c)
 
1,479,017
15,204,295
SPS Commerce Inc (c)
 
243,884
34,999,793
Tenable Holdings Inc (c)
 
651,879
19,927,941
Varonis Systems Inc (c)
 
395,590
16,947,076
Weave Communications Inc (c)
 
2,794,970
29,626,682
Workiva Inc Class A (c)
 
438,170
32,981,056
 
 
 
509,667,859
TOTAL INFORMATION TECHNOLOGY
 
 
935,771,940
 
 
 
 
Materials - 4.2%
 
 
 
Chemicals - 1.6%
 
 
 
Axalta Coating Systems Ltd (c)
 
1,644,463
53,445,048
Cabot Corp
 
428,138
33,625,959
Element Solutions Inc
 
925,407
18,887,556
 
 
 
105,958,563
Construction Materials - 0.3%
 
 
 
Eagle Materials Inc
 
81,607
18,475,009
Metals & Mining - 1.8%
 
 
 
ATI Inc (c)
 
528,507
28,740,211
Carpenter Technology Corp
 
457,105
89,414,309
 
 
 
118,154,520
Paper & Forest Products - 0.5%
 
 
 
Louisiana-Pacific Corp
 
407,524
35,173,396
TOTAL MATERIALS
 
 
277,761,488
 
 
 
 
Real Estate - 1.7%
 
 
 
Hotel & Resort REITs - 0.3%
 
 
 
Ryman Hospitality Properties Inc
 
238,007
20,932,716
Industrial REITs - 0.3%
 
 
 
Terreno Realty Corp
 
314,992
17,743,499
Real Estate Management & Development - 1.1%
 
 
 
Compass Inc Class A (c)
 
5,584,938
43,115,722
Landbridge Co LLC Class A (b)
 
373,347
27,048,990
 
 
 
70,164,712
TOTAL REAL ESTATE
 
 
108,840,927
 
 
 
 
Utilities - 0.2%
 
 
 
Electric Utilities - 0.2%
 
 
 
IDACORP Inc
 
133,520
15,767,377
TOTAL UNITED STATES
 
 
5,909,779,947
 
TOTAL COMMON STOCKS
 (Cost $5,634,879,485)
 
 
 
6,468,485,840
 
 
 
 
Convertible Corporate Bonds - 0.0%
 
 
Principal
Amount (a)
 
Value ($)
 
UNITED STATES - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Health Care Technology - 0.0%
 
 
 
Wugen Inc 10% 6/14/2025 (e)(f)
  (Cost $1,379,633)
 
1,379,633
1,422,816
 
 
 
 
Convertible Preferred Stocks - 1.3%
 
 
Shares
Value ($)
 
UNITED STATES - 1.3%
 
 
 
Health Care - 0.4%
 
 
 
Biotechnology - 0.4%
 
 
 
Bright Peak Therapeutics Inc. Series B (c)(e)(f)
 
1,079,522
1,565,307
Bright Peak Therapeutics Inc. Series C (c)(e)(f)
 
2,205,558
2,315,836
Caris Life Sciences Inc Series D (c)(e)(f)
 
780,603
4,293,317
Endeavor BioMedicines Inc Series C (c)(e)(f)
 
556,156
2,719,603
LifeMine Therapeutics Inc Series C (c)(e)(f)
 
2,048,403
2,417,116
Sonoma Biotherapeutics Inc Series B (c)(e)(f)
 
2,370,360
5,736,271
Sonoma Biotherapeutics Inc Series B1 (c)(e)(f)
 
1,264,171
3,527,037
T-Knife Therapeutics Inc Series B (c)(e)(f)
 
1,097,257
1,492,269
Treeline Biosciences Series A (c)(e)(f)
 
115,000
600,299
 
 
 
24,667,055
Health Care Technology - 0.0%
 
 
 
Wugen Inc Series B (c)(e)(f)
 
326,496
421,180
TOTAL HEALTH CARE
 
 
25,088,235
 
 
 
 
Industrials - 0.5%
 
 
 
Construction & Engineering - 0.5%
 
 
 
Beta Technologies Inc Series A (c)(e)(f)
 
278,129
24,091,534
Beta Technologies Inc Series B, 6% (c)(e)(f)
 
85,106
8,808,471
 
 
 
32,900,005
Information Technology - 0.4%
 
 
 
Communications Equipment - 0.2%
 
 
 
Astranis Space Technologies Corp Series C (c)(e)(f)
 
557,717
6,190,659
Astranis Space Technologies Corp Series C (c)(e)(f)
 
87,241
968,375
Astranis Space Technologies Corp Series D (c)(e)(f)
 
620,825
4,774,144
 
 
 
11,933,178
IT Services - 0.0%
 
 
 
Yanka Industries Inc Series E (c)(e)(f)
 
869,641
2,278,460
Yanka Industries Inc Series F (c)(e)(f)
 
127,716
537,684
 
 
 
2,816,144
Software - 0.2%
 
 
 
Algolia Inc Series D (c)(e)(f)
 
53,800
839,280
Lyte Ai Inc Series B (e)(f)
 
97,800
1,084,602
Mountain Digital Inc Series D (c)(e)(f)
 
729,676
9,514,975
Skyryse Inc Series B (c)(e)(f)
 
62,100
1,609,011
 
 
 
13,047,868
TOTAL INFORMATION TECHNOLOGY
 
 
27,797,190
 
 
 
 
TOTAL UNITED STATES
 
 
85,785,430
 
TOTAL CONVERTIBLE PREFERRED STOCKS
 (Cost $123,810,746)
 
 
 
85,785,430
 
 
 
 
Domestic Equity Funds - 0.0%
 
 
Shares
Value ($)
 
iShares Russell 2000 Growth ETF
 (Cost $2,811,631)
 
11,200
2,839,760
 
 
 
 
Money Market Funds - 7.8%
 
 
Yield (%)
Shares
Value ($)
 
Fidelity Cash Central Fund (j)
 
4.33
4,783,261
4,784,217
Fidelity Securities Lending Cash Central Fund (j)(k)
 
4.33
509,695,132
509,746,102
 
TOTAL MONEY MARKET FUNDS
 (Cost $514,530,319)
 
 
 
514,530,319
 
 
 
 
 
 
TOTAL INVESTMENT IN SECURITIES - 107.9%
 (Cost $6,277,411,814)
 
 
 
7,073,064,165
NET OTHER ASSETS (LIABILITIES) - (7.9)%  
(517,966,042)
NET ASSETS - 100.0%
6,555,098,123
 
 
Security Type Abbreviations
ETF
-
EXCHANGE-TRADED FUND
 
Legend
 
(a)
Amount is stated in United States dollars unless otherwise noted.
 
(b)
Security or a portion of the security is on loan at period end.
 
(c)
Non-income producing
 
(d)
Security is exempt from registration under Regulation S of the Securities Act of 1933 and may be resold to qualified foreign investors outside of the United States. At the end of the period, the value of securities amounted to $13,413,675 or 0.2% of net assets.
 
(e)
Level 3 security
 
(f)
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $201,295,934 or 3.1% of net assets.
 
(g)
Affiliated company
 
(h)
Security or a portion of the security purchased on a delayed delivery or when-issued basis.
 
(i)
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
 
(j)
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
 
(k)
Investment made with cash collateral received from securities on loan.
 
 
 
At period end, the value of non-cash collateral for securities on loan amounted to $1,457,984.
 
 
 
Additional information on each restricted holding is as follows:
Security
Acquisition Date
Acquisition Cost ($)
 
Aerovate Therapeutics Inc
10/30/24
3,279,997
 
 
 
Algolia Inc
10/27/21
6,862,059
 
 
 
Algolia Inc Series D
7/23/21
1,573,384
 
 
 
Astranis Space Technologies Corp Series C
3/19/21
12,225,675
 
 
 
Astranis Space Technologies Corp Series C
4/05/23
1,912,404
 
 
 
Astranis Space Technologies Corp Series D
4/25/24 - 12/06/24
5,799,995
 
 
 
Beta Technologies Inc Series A
4/09/21
20,378,512
 
 
 
Beta Technologies Inc Series B, 6%
4/04/22
8,780,386
 
 
 
Bright Peak Therapeutics Inc. Series B
5/14/21
4,216,613
 
 
 
Bright Peak Therapeutics Inc. Series C
5/07/24
2,500,000
 
 
 
Caris Life Sciences Inc Series D
5/11/21
6,322,884
 
 
 
Endeavor BioMedicines Inc Series C
4/22/24
3,628,695
 
 
 
Enliven Therapeutics Inc
3/19/24
3,736,698
 
 
 
Fanatics Inc Class A
8/13/20 - 3/22/21
12,874,623
 
 
 
GlycoMimetics Inc
10/28/24
1,500,000
 
 
 
LifeMine Therapeutics Inc Series C
2/15/22
4,171,757
 
 
 
Lyte Ai Inc Series B
8/13/24
1,240,701
 
 
 
Mountain Digital Inc Series D
11/05/21
16,757,228
 
 
 
Perella Weinberg Partners
12/29/20
20,395,000
 
 
 
Skyryse Inc Series B
10/21/21
1,532,626
 
 
 
Sonoma Biotherapeutics Inc Series B
7/26/21
4,684,542
 
 
 
Sonoma Biotherapeutics Inc Series B1
7/26/21
3,747,635
 
 
 
Starling Bank Ltd Class D
6/18/21 - 4/05/22
3,728,430
 
 
 
T-Knife Therapeutics Inc Series B
6/30/21
6,329,856
 
 
 
Treeline Biosciences Series A
7/30/21
900,163
 
 
 
Veterinary Emergency Group
9/16/21 - 3/17/22
9,386,716
 
 
 
Wugen Inc 10% 6/14/2025
6/14/24
1,379,633
 
 
 
Wugen Inc Series B
7/09/21
2,531,944
 
 
 
Yanka Industries Inc Series E
5/15/20
10,504,568
 
 
 
Yanka Industries Inc Series F
4/08/21
4,071,177
 
 
 
 
 
Affiliated Central Funds
 
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
 
 
Shares,
end
of period
% ownership,
end
of period
Fidelity Cash Central Fund
52,503,286
1,232,347,676
1,280,066,745
893,135
-
-
4,784,217
4,783,261
0.0%
Fidelity Securities Lending Cash Central Fund
277,060,862
1,794,421,779
1,561,736,539
974,279
-
-
509,746,102
509,695,132
1.7%
Total
329,564,148
3,026,769,455
2,841,803,284
1,867,414
-
-
514,530,319
 
 
 
 
 
 
 
 
 
 
 
 
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
 
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium income received for lending certain types of securities.
 
Other Affiliated Issuers
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are presented in the table below. Certain corporate actions, such as mergers, are excluded from the amounts in this table if applicable. A dash in the Value end of period ($) and Shares end of period columns means either the issuer is no longer held at period end, or the issuer is held at period end but is no longer an affiliate.
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
 
 
Shares,
end
of period
GlycoMimetics Inc
-
1,500,000
-
-
-
1,225,986
2,725,986
12,099,897
Lovesac
32,890,851
-
28,922,093
-
(7,550,624)
3,581,866
-
-
Soleno Therapeutics Inc
-
30,492,931
51,425
-
594
1,965,543
32,407,643
432,910
Total
32,890,851
31,992,931
28,973,518
-
(7,550,030)
6,773,395
35,133,629
 
 
 
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.   
 
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
 
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
 
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
 
Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach, and are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities.
 
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Convertible Corporate Bonds are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
 
Exchange-Traded Funds (ETFs) and Exchange-Traded Notes (ETNs) are valued at their last sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day but the exchange reports a closing bid level, ETFs and ETNs are valued at the closing bid and would be categorized as Level 1 in the hierarchy. In the event there was no closing bid, ETFs and ETNs may be valued by another method that the Board believes reflects fair value in accordance with the Board's fair value pricing policies and may be categorized as Level 2 in the hierarchy.
 
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
 
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
 
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
 
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
 
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.